Novel Biomarkers Improve Diagnosis in Rheumatoid Arthritis, Hasselt University Study
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Data presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, show that novel antibody biomarkers could significantly improve diagnosis in rheumatoid arthritis (RA). Four candidate biomarkers – UH-RA.1, UH-RA.9, UH-RA.14 and UH-RA.21 – were investigated; as a group they demonstrated 85% specificity for RA, and were present in both early and seronegative disease, with 36% of early RA and 24% of RF- and ACCP -negative patients testing positive.
Hey, check out all the engineering jobs. Post your resume today!
Data presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, show that novel antibody biomarkers could significantly improve diagnosis in rheumatoid arthritis (RA). Four candidate biomarkers – UH-RA.1, UH-RA.9, UH-RA.14 and UH-RA.21 – were investigated; as a group they demonstrated 85% specificity for RA, and were present in both early and seronegative disease, with 36% of early RA and 24% of RF- and ACCP -negative patients testing positive.
Hey, check out all the engineering jobs. Post your resume today!